Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

D M Monroe

Showing results (51-60 of 83) with videos related to

Pageof 9
Sort By:
Biochemistry|December 31, 1985
Comparison of lipid binding and kinetic properties of normal, variant, and gamma-carboxyglutamic acid modified human factor IX and factor IXaM E Jones, M J Griffith, D M Monroe, et al.
Thrombosis and Haemostasis|March 11, 1998
Cloning, expression, and characterization of mouse tissue factor pathway inhibitor (TFPI)J Y Chang, D M Monroe, J A Oliver, et al.
Blood|January 15, 1992
Role of gamma-carboxyglutamic acid residues in the binding of factor IXa to platelets and in factor-X activationR Rawala-Sheikh, S S Ahmad, D M Monroe, et al.
Archives of Biochemistry and Biophysics|May 1, 1985
Activation of normal and abnormal human factor IX with trypsinD M Monroe, C M Noyes, D L Straight, et al.
Thrombosis and Haemostasis|November 3, 1998
Active site-inactivated factors VIIa, Xa, and IXa inhibit individual steps in a cell-based model of tissue factor-initiated coagulationM Kjalke, D M Monroe, M Hoffman, et al.
The Journal of Biological Chemistry|December 5, 1990
Comparative platelet binding and kinetic studies with normal and variant factor IXa moleculesS S Ahmad, R Rawala-Sheikh, D M Monroe, et al.
Thrombosis Research|December 1, 1989
Mechanism by which recombinant factor VIIa shortens the aPTT: activation of factor X in the absence of tissue factorD S Telgt, B G Macik, D M McCord, et al.
Biochemistry|August 26, 1986
p-Amidino esters as irreversible inhibitors of factors IXa and Xa and thrombinA D Turner, D M Monroe, H R Roberts, et al.
The Journal of Clinical Investigation|August 15, 1997
Replacing the first epidermal growth factor-like domain of factor IX with that of factor VII enhances activity in vitro and in canine hemophilia BJ Y Chang, D M Monroe, D W Stafford, et al.
Infection and Immunity|November 1, 1982
Type-specific antibodies to structurally defined fragments of streptococcal M proteins in patients with acute rheumatic feverA L Bisno, X Berrios, F Quesney, et al.
Pageof 9

Showing results (51-60 of 83) with videos related to

Sort By:
Pageof 9
Biochemistry|December 31, 1985
Comparison of lipid binding and kinetic properties of normal, variant, and gamma-carboxyglutamic acid modified human factor IX and factor IXaM E Jones, M J Griffith, D M Monroe, et al.
Thrombosis and Haemostasis|March 11, 1998
Cloning, expression, and characterization of mouse tissue factor pathway inhibitor (TFPI)J Y Chang, D M Monroe, J A Oliver, et al.
Blood|January 15, 1992
Role of gamma-carboxyglutamic acid residues in the binding of factor IXa to platelets and in factor-X activationR Rawala-Sheikh, S S Ahmad, D M Monroe, et al.
Archives of Biochemistry and Biophysics|May 1, 1985
Activation of normal and abnormal human factor IX with trypsinD M Monroe, C M Noyes, D L Straight, et al.
Thrombosis and Haemostasis|November 3, 1998
Active site-inactivated factors VIIa, Xa, and IXa inhibit individual steps in a cell-based model of tissue factor-initiated coagulationM Kjalke, D M Monroe, M Hoffman, et al.
The Journal of Biological Chemistry|December 5, 1990
Comparative platelet binding and kinetic studies with normal and variant factor IXa moleculesS S Ahmad, R Rawala-Sheikh, D M Monroe, et al.
Thrombosis Research|December 1, 1989
Mechanism by which recombinant factor VIIa shortens the aPTT: activation of factor X in the absence of tissue factorD S Telgt, B G Macik, D M McCord, et al.
Biochemistry|August 26, 1986
p-Amidino esters as irreversible inhibitors of factors IXa and Xa and thrombinA D Turner, D M Monroe, H R Roberts, et al.
The Journal of Clinical Investigation|August 15, 1997
Replacing the first epidermal growth factor-like domain of factor IX with that of factor VII enhances activity in vitro and in canine hemophilia BJ Y Chang, D M Monroe, D W Stafford, et al.
Infection and Immunity|November 1, 1982
Type-specific antibodies to structurally defined fragments of streptococcal M proteins in patients with acute rheumatic feverA L Bisno, X Berrios, F Quesney, et al.
Pageof 9